期刊文献+

雾化吸入羟基喜树碱内酯/羧酸盐在豚鼠体内的分布

Investigation of distribution on lactone/carboxylate of hydroxycamptothecin after aerosol inhalation in cavia cobaya
原文传递
导出
摘要 目的:研究比较雾化吸入与静脉注射羟基喜树碱(HCPT)后,主要活性形式内酯型(L-HCPT)和弱活性形式羧酸盐型(C-HCPT)2种不同结构在豚鼠组织及血浆中的分布情况以及两者比值随时间变化的规律。方法:建立HPLC-FLD法测定豚鼠血浆及各组织中内酯型及羧酸盐型羟基喜树碱的药物浓度。比较静脉注射和雾化吸入后豚鼠各组织中内酯/羧酸盐比例随时间的变化。结果:相对于静脉注射途径,采用雾化吸入后,各组织中内酯/羧酸盐的比例均有所提高,尤以肺组织最为明显,肺组织中L-HCPT的AUC占各组织中总的AUC的比值为静脉注射的6.96倍,而肝、肾组织中L-HCPT的AUC占各组织中总的AUC的比值分别下降为静脉注射的33.5%和55%。结论:雾化吸入给药后,在提高肺组织中内酯型药物浓度的同时还能显著降低药物在其他组织的浓度,从而降低了对其他组织的毒性,更有利于肺癌的治疗。 OBJECTIVE To study the distribution of LHCPT and C-HCPT in plasma and tissue of cavia cobaya after aero sol inhalation and iv administration of HCPT, and study the regularity on lactone/carboxylate rate with time. METHODS HPLC-FLD was used to determine the concentration of L-HCPT and C-HCPT in plasma and different tissues of cavia cobaya. The regulation on lactone/carboxylate rate of hydroxycamptothecin was compared after aerosol inhalation or iv administration. RESULTS The lactone/carboxylate rate in tissues after aerosol inhalation was higher than that of iv administration,especially in lung; the ratio that AUC of L-HCPT in lung accounted for AUC of overall tissues after aerosol inhalation was 6. 96 times compared to iv administration, but it has descended to 33.5% and 55 % compared to iv administration in liver and kidney. CONCLUSION Aerosol inhalation possessed a certain degree of lung targeting,it could raise the concentration of L-HCPT in lung, at the same time decrease the concentration in any other tissues, accordingly decrease the tissue toxicity, which is good for the curing of lung cancer.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第21期1820-1823,共4页 Chinese Journal of Hospital Pharmacy
基金 江苏省卫生厅奥赛康项目(编号:P200403)
关键词 羟基喜树碱 雾化吸入 组织分布 内酯/羧酸盐 hydroxycamptothecin aerosol inhalation tissue distribution lactone/carboxylate
  • 相关文献

参考文献5

二级参考文献22

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:31
  • 2周卫,平其能,王丽杰.羟喜树碱脂质体的粒径对组织分布的影响[J].中国药科大学学报,2005,36(2):125-128. 被引量:15
  • 3Hertzberg RP, Caranfa M J, Holden KG, et al.Modification of the hydroxy lactone ring of camptothecin:inhibition of mammalian topoisomerase Ⅰ and biological activity [ J]. J Med Chem, 1989,32(3) :715 - 720.
  • 4Burke TG, MI Z. The structure basis of camptothecin interactions with human serum albumin: impact on drug stability [J]. J Med Chem, 1994,37( 1 ) :40 -46.
  • 5Zhong DF, Li K, Xu JH, et al. Pharmacokinetics of 9-nitro-20 (S) -camptothecin in rats [ J ]. Acta Pharmacol Sin, 2003,24( 3 ) :256 - 262.
  • 6Loos W J, Sparreboom A, Verweij J, et al. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive highperformance liquid chromatography with fluorescence detection [ J ]. J Chromatogr B, 1997,694:435 - 441.
  • 7Cao Z, Harris N, Kozielski A, et al. Alkyl esters of camptothecin and 9-nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity [ J]. J Med Chem, 1998,41( 1 ) :31 -37.
  • 8Scott DO, Bindra DS, Stella VJ. Plasma pharmacokinetics of the lactone and carboxylate forms of 20 ( S ) -camptothecin in anesthetized rats [ J ]. Pharm Res, 1993,10(10) :1451 - 1457.
  • 9Chow DS, Gong L, Wolfe MD, et al. Modified lactone/carboxylate salt equilibrium in vivo by liposomal delivery of 9-nitrocamptothecin [ J]. Ann NY Acad Sci, 2000,922:164 - 174.
  • 10Li YF, Zhang RW. Reversed-phase high performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues [ J ].J Chromatogr B, 1996,686:257 - 265.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部